Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
LKFT holding history
Lakefront Biotherapeutics NV in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LKFT overviewAll 13F holders of LKFTFull Q2 2026 holdings
- Shares (Q2 2026)
- 25,600
- Value
- $767.5K
- % of portfolio
- 0.3%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 25,600 | $767.5K | 0.3% | −1,920−7.0% | Reduced | Holders |
| Q1 2026 | 27,520 | $825.6K | 0.3% | −5,000−15.4% | Reduced | Holders |
| Q4 2025 | 32,520 | $1.06M | 0.3% | −1,016−3.0% | Reduced | Holders |
| Q3 2025 | 33,536 | $1.16M | 0.4% | −2,500−6.9% | Reduced | Holders |
| Q2 2025 | 36,036 | $1.01M | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2025 | 36,036 | $905.2K | 0.5% | +21,036+140.2% | Added | Holders |
| Q4 2024 | 15,000 | $412.5K | 0.2% | −5,999−28.6% | Reduced | Holders |
| Q3 2024 | 20,999 | $604.6K | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 20,999 | $520.4K | 0.3% | +4,255+25.4% | Added | Holders |
| Q1 2024 | 16,744 | $539.2K | 0.2% | +10,000+148.3% | Added | Holders |
| Q4 2023 | 6,744 | $274.1K | 0.1% | −1,714−20.3% | Reduced | Holders |
| Q3 2023 | 8,458 | $292.2K | 0.1% | +313+3.8% | Added | Holders |
| Q2 2023 | 8,145 | $331.2K | 0.2% | −15,975−66.2% | Reduced | Holders |
| Q1 2023 | 24,120 | $932.0K | 0.4% | +5,442+29.1% | Added | Holders |
| Q4 2022 | 18,678 | $828.9K | 0.3% | +8,678+86.8% | Added | Holders |
| Q3 2022 | 10,000 | $426.0K | 0.2% | +10,000 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −17,000−100.0% | Sold out | Holders |
| Q1 2022 | 17,000 | $1.05M | 0.6% | −80,064−82.5% | Reduced | Holders |
| Q4 2021 | 97,064 | $5.35M | 3.3% | – | No prior filing | Holders |